Siok Min Teoh

Siok Min Teoh

Auto-generated profile, based on publicly available information

Siok Min Teoh

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Janin ChandraJanin Chandra
Janin Chandra
STSiok Min Teoh
Siok Min Teoh
PKPaula Kuo
Paula Kuo
LTLynn Tolley
Lynn Tolley
ABAbate Assefa Bashaw
Abate Assefa Bashaw
MYMeihua Yu
Meihua Yu
Prophylactic human papillomavirus (HPV) vaccines are commercially available for prevention of infection with cancerogenic HPV genotypes but are not able to combat pre-existing HPV-associated disease. In this study, we designed a nanomaterial-based therapeutic HPV vaccine, comprising manganese (Mn4+)-doped silica nanoparticles (Mn4+-SNPs) and the viral neoantigen peptide GF001 derived from the HPV16 E7 oncoprotein. We show in mice that Mn4+-SNPs act as self-adjuvants by activating the inflammatory signaling pathway via generation of reactive oxygen species, resulting in immune cell recruitment to the immunization site and dendritic cell maturation. Mn4+-SNPs further serve as Ag carriers by facilitating endo/lysosomal escape via depletion of protons in acidic endocytic compartments and subsequent Ag delivery to the cytosol for cross-presentation. The Mn4+-SNPs+GF001 nanovaccine induced strong E7-specific CD8+ T cell responses, leading to remission of established murine HPV16 E7-expressing solid TC-1 tumors and E7-expressing transgenic skin grafts. This vaccine construct offers a simple and general strategy for therapeutic HPV and potentially other cancer vaccines. Key Points Mn delivered by silica-based nanoparticles conveys ROS-associated adjuvancy. Nanoadjuvant drives DC activation and Ag cross-presentation. Nanoadjuvant induces tumor-eliminating cytotoxic cellular immune response in vivo.

1 June 2018 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PKPaula Kuo
Paula Kuo
ZTZewen Tuong
Zewen Tuong
STSiok Min Teoh
Siok Min Teoh
IFIan Frazer
Ian Frazer
SMStephen R. Mattarollo
Stephen R. Mattarollo
GLGraham R. Leggatt
Graham R. Leggatt

1 June 2018 in Papillomavirus Research
Verified
Journal Article
Open access
ZTZewen Tuong
Zewen Tuong
KNK. Noske
K. Noske
PKP. Kuo
P. Kuo
ABA.A. Bashaw
A.A. Bashaw
STS.M. Teoh
S.M. Teoh
IFIan Frazer
Ian Frazer
Currently available vaccines prevent HPV infection and development of HPV-associated malignancies, but do not cure existing HPV infections and dysplastic lesions. Persistence of infection(s) in immunocompetent patients may reflect induction of local immunosuppressive mechanisms by HPV, providing a target for therapeutic intervention. We have proposed that a mouse, expressing HPV16 E7 oncoprotein under a Keratin 14 promoter (K14E7 mice), and which develops epithelial hyperplasia, may assist with understanding local immune suppression mechanisms that support persistence of HPV oncogene-induced epithelial hyperplasia. K14E7 skin grafts recruit immune cells from immunocompetent hosts, but consistently fail to be rejected. Here, we review the literature on HPV-associated local immunoregulation, and compare the findings with published observations on the K14E7 transgenic murine model, including comparison of the transcriptome of human HPV-infected pre-malignancies with that of murine K14E7 transgenic skin. We argue from the similarity of i) the literature findings and ii) the transcriptome profiles that murine K14E7 transgenic skin recapitulates the cellular and secreted protein profiles of high-grade HPV-associated lesions in human subjects. We propose that the K14E7 mouse may be an appropriate model to further study the immunoregulatory effects of HPV E7 expression, and can facilitate development and testing of therapeutic vaccines.

1 December 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ABAbate Assefa Bashaw
Abate Assefa Bashaw
STSiok M. Teoh
Siok M. Teoh
ZTZewen Tuong
Zewen Tuong
Graham LeggattGraham Leggatt
Graham Leggatt
IFIan Frazer
Ian Frazer
Janin ChandraJanin Chandra
Janin Chandra

18 December 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
PKPaula Kuo
Paula Kuo
STSiok Min Teoh
Siok Min Teoh
ZTZewen Tuong
Zewen Tuong
GLGraham R. Leggatt
Graham R. Leggatt
SMStephen R. Mattarollo
Stephen R. Mattarollo
IFIan Frazer
Ian Frazer
“High-risk” human papillomaviruses (HPV) infect keratinocytes of squamous epithelia. The HPV16E7 protein induces epithelial hyperplasia by binding Rb family proteins and disrupting cell cycle termination. Murine skin expressing HPV16E7 as a transgene from a keratin 14 promoter (K14.E7) demonstrates epithelial hyperplasia, dysfunctional antigen presenting cells, ineffective antigen presentation by keratinocytes, and production of immunoregulatory cytokines. Furthermore, grafted K14.E7 skin is not rejected from immunocompetent non-transgenic recipient animals. To establish the contributions of E7, of E7-Rb interaction and of epithelial hyperplasia to altered local skin immunity, K14.E7 skin was compared with skin from K14.E7 mice heterozygous for a mutant Rb unable to bind E7 (K14.E7xRbΔL/ΔL mice), that have normoplastic epithelium. Previously, we demonstrated that E7-speicfic T cells do not accumulate in K14.E7xRbΔL/ΔL skin grafts. Here, we further show that K14.E7xRbΔL/ΔL skin, like K14.E7 skin, is not rejected by immunocompetent non-transgenic animals. There were fewer CD11b+ antigen presenting cells in skin draining lymph nodes from animals recipient of K14.E7xRbΔL/ΔL grafts, when compared with animals receiving K14.E7 grafts or K5mOVA grafts. Maturation of migratory DCs derived from K14.E7xRbΔL/ΔL grafts found in the draining lymph nodes is significantly lower than that of K14.E7 grafts. Surprisingly, K14.E7xRbΔL/ΔL keratinocytes, unlike K14.E7 keratinocytes, are susceptible to E7 directed CTL-mediated lysis in vitro. We conclude that E7-Rb interaction and its associated epithelial hyperplasia partially contribute to the suppressive local immune responses in area affected by HPV16E7 expression.

2 December 2024 in Nano Letters
Verified
Journal Article
Closed access
WJWencong Jia
Wencong Jia
JCJanin Chandra
Janin Chandra
STSiok Min Teoh
Siok Min Teoh
LTLynn Tolley
Lynn Tolley
HYHaotian Yang
Haotian Yang
MYMeihua Yu
Meihua Yu